Colgate-Palmolive (NYSE:CL) Shares Purchased by TD Asset Management Inc

TD Asset Management Inc boosted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 1,184,713 shares of the company’s stock after acquiring an additional 30,147 shares during the quarter. TD Asset Management Inc owned about 0.14% of Colgate-Palmolive worth $114,965,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Foundations Investment Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at $225,000. Wealth Effects LLC acquired a new position in Colgate-Palmolive during the second quarter valued at $210,000. Simon Quick Advisors LLC boosted its holdings in Colgate-Palmolive by 4.6% in the second quarter. Simon Quick Advisors LLC now owns 5,935 shares of the company’s stock valued at $576,000 after purchasing an additional 262 shares during the last quarter. Cozad Asset Management Inc. grew its position in Colgate-Palmolive by 5.2% during the 2nd quarter. Cozad Asset Management Inc. now owns 5,761 shares of the company’s stock worth $559,000 after purchasing an additional 284 shares during the period. Finally, Founders Financial Securities LLC raised its stake in shares of Colgate-Palmolive by 3.0% during the 2nd quarter. Founders Financial Securities LLC now owns 5,783 shares of the company’s stock valued at $561,000 after buying an additional 167 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sally Massey sold 15,850 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CL shares. Barclays upped their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Bank of America upped their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. TD Cowen lifted their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Finally, Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $102.53.

Get Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Down 0.2 %

Shares of CL stock opened at $108.52 on Friday. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The stock’s fifty day moving average is $100.86 and its two-hundred day moving average is $94.28. The firm has a market capitalization of $89.03 billion, a P/E ratio of 34.34, a PEG ratio of 3.73 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a $0.50 dividend. The ex-dividend date was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.84%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.